Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care

Paul Goode, President & CEO, GlucoTrack GCTK, was recently a guest on Benzinga's All-Access.

GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company's vision is to create a future where diabetes management is automatic and inconspicuous, empowering people to live boldly and unapologetically.

Learn more here:

Featured photo by Towfiqu barbhuiya on Unsplash.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.